Alpha 2.0
Login Register
» Articles » PMID: 19425063

Effects of RANTES and MBL2 Gene Polymorphisms in Sickle Cell Disease Clinical Outcomes: Association of the G.In1.1T>C RANTES Variant with Protection Against Infections

Overview
Journal Am J Hematol
Specialty Hematology
Date 2009 May 9
PMID 19425063
Citations 6
Authors
Omer Placide Dossou-Yovo
Isabelle Zaccaria
Malika Benkerrou
Michelle Hauchecorne
Corinne Alberti
Mohamed Cherif Rahimy
Jacques Elion
Claudine Lapoumeroulie
Affiliations
Soon will be listed here.
Citing Articles

Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.

Kirkham J, Estepp J, Weiss M, Rashkin S JAMA Netw Open. 2023; 6(10):e2337484.

PMID: 37851445 PMC: 10585422. DOI: 10.1001/jamanetworkopen.2023.37484.

The Relationship of and Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma.

Popek-Marciniec S, Styk W, Wojcierowska-Litwin M, Szudy-Szczyrek A, Dudek P, Swiderska-Kolacz G J Clin Med. 2023; 12(6).

PMID: 36983384 PMC: 10056693. DOI: 10.3390/jcm12062384.

Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.

Habara A, Steinberg M Exp Biol Med (Maywood). 2016; 241(7):689-96.

PMID: 26936084 PMC: 4950383. DOI: 10.1177/1535370216636726.

Frequency of RANTES gene polymorphisms and their association with incidence of malaria: a longitudinal study on children in Iganga district, Uganda.

Lwanira C, Mukasa M, Swedberg G, Kironde F Malar J. 2015; 14:341.

PMID: 26341782 PMC: 4560921. DOI: 10.1186/s12936-015-0875-0.

Genomic approaches to identifying targets for treating β hemoglobinopathies.

Ngo D, Steinberg M BMC Med Genomics. 2015; 8:44.

PMID: 26215470 PMC: 4517356. DOI: 10.1186/s12920-015-0120-2.